ASN-1901

N/A

Report date: 2023/05/17 13:53:34
NME

Base Information

Drug NameASN-1901
Drug Alias NameASN-1901
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEstrogen receptors degraders
TargetsEstrogen receptors
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesAsieris Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAsieris Pharmaceuticals Ltd
Inactive CompaniesN/A
Active IndicationsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A